Anti-Influenza A Potential of Tagetes erecta Linn. Extract Based on Bioinformatics Analysis and In Vitro Assays
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137065 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Minjee Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, Plant Extracts, Computational Biology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Food and Drug Safety and the Korean Health Technology R&D Project, Ministry of Food and Drug Safety, Korean Health Technology R&D Project.
Abstract (Originalsprache)
Tagetes erecta Linn. (TE) is traditionally used to treat cardiovascular, renal, and gastrointestinal diseases. In this study, we investigated the active compounds and targets of TE extract that may exert antiviral effects against influenza A. Active compounds and targets of TE extract were identified using the Traditional Chinese Medicine Systems Pharmacology database (TCSMP). The influenza A-related gene set was screened using GeneCards and the Kyoto Encyclopedia of Genes and Genomes (KEGG). A protein–protein interaction (PPI) network was built to establish the hub targets. Pathway and target studies were conducted using Gene Expression Omnibus (GEO). The interactions between active compounds and potential targets were assessed by molecular docking. An in vitro study was performed using antiviral and plaque reduction assays. From the compound and target search, we identified 6 active compounds and 95 potential targets. We retrieved 887 influenza-associated target genes and determined 14 intersecting core targets between TE and influenza. After constructing a compound–target network, we discovered lutein and beta-carotene to be the key compounds. Next, PPI network analysis identified the top three hub genes associated with influenza (IL-6, HIF1A, and IL-1β). Similarly, GEO analysis revealed IL-6, TGFB1, and CXCL8 to be the top three target genes. In our docking study, we identified that lutein and IL-6 had the strongest bindings. Our in vitro experimental results revealed that the TE extract exhibited therapeutic rather than prophylactic effects on influenza disease. We identified lutein as a main active compound in TE extract, and IL-6 as an important target associated with influenza, by using data mining and bioinformatics. Our in vitro findings indicated that TE extract exerted protective properties against the influenza A virus. We speculated that lutein, as a key active component in TE extract, is largely responsible for its antiviral effects. Therefore, we suggest TE extract as an alternative in the treatment of influenza.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Young Bong Kim
Förderung
- the Ministry of Food and Drug Safety and the Korean Health Technology R&D Project
- Ministry of Food and Drug Safety
- Korean Health Technology R&D Project
Zitieren
APA
Kim, M., Nowakowska, A., Kim, J., & Kim, Y. B. (2024). Anti-Influenza A Potential of Tagetes erecta Linn. Extract Based on Bioinformatics Analysis and In Vitro Assays. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137065
Vancouver
Kim M, Nowakowska A, Kim J, Kim YB. Anti-Influenza A Potential of Tagetes erecta Linn. Extract Based on Bioinformatics Analysis and In Vitro Assays. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137065
BibTeX
@article{Kim2024,
author = {Kim, Minjee and Nowakowska, Aleksandra and Kim, Jaebum and Kim, Young Bong},
title = {Anti-Influenza A Potential of Tagetes erecta Linn. Extract Based on Bioinformatics Analysis and In Vitro Assays},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137065}
}
EUVIMED